Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares Gold Trust (IAU) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance

iShares Gold TrustTrade
Vaxcyte Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares Gold Trust vs Vaxcyte Inc. Common Stock — how do they compare? iShares Gold Trust trades at $77.86 (market cap $62.13B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: iShares Gold Trust is far larger — about 5.9× Vaxcyte Inc. Common Stock's market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, iShares Gold Trust nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Gold Trust for 51 Days and Vaxcyte Inc. Common Stock for 0 Days on average.

IAUPCVX
Market Cap
$62.13B$10.51B
Volume
3,713,0952,644,694
Sector
Commodities - Metals/AgricultureHealth
52-Week High
$101.57$73.82
52-Week Low
$74.21$40.32
Typical Hold Time
51 Days0 Days
Enterprise Value
—$9.14B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares Gold Trust

IAU shares are trading at $78.25, down 0.11% with bearish technical signals dominating the short-term outlook. The stock faces pressure from rising Treasury yields and Federal Reserve rate uncertainty, though recent soft inflation data has provided some support. Technical indicators show selling pressure outweighing buying signals, with moving averages pointing downward and key resistance at $79.

The stock faces headwinds from monetary policy uncertainty and yield pressures, but potential exists if inflation concerns resurface. Key risks include continued rate hike expectations and dollar strength, while opportunities may emerge from safe-haven demand during market volatility. The technical setup suggests caution in the near term with support at $78.

Vaxcyte Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IAU
53% Buy47% Sell
Avg holding period · 51 Days
PCVX
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About iShares Gold Trust

IAU is a physically backed ETF that seeks to reflect the performance of the price of gold. It provides a convenient and liquid way for investors to include gold in their portfolios as a potential hedge.

Read more on IAU →

About Vaxcyte Inc. Common Stock

Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.

Read more on PCVX →